Pfizer is one of the world’s leading research-based biopharmaceutical companies. The company was founded in 1849 in Brooklyn, NY. Our purpose is to innovate to bring therapies to patients that extend and significantly improve their lives.
Pfizer’s 2015 global revenues totaled USD $48.9 billion, and the company invested more than USD $7.69 billion in research and development for the year. Worldwide, Pfizer has approximately 97,000 employees, 65 global manufacturing facilities and operations in 175 markets.
Pfizer began its business operations in China in 1989 and is now the country’s largest multinational biopharmaceutical company, with a presence in more than 300 cities nationwide and a staff of more than 10,000.
Pfizer has strengthened its work in recent years to play a vital role in China’s ever-changing healthcare system. We promote the enhancement of Chinese people’s health and the country’s healthcare industry. We work to meet the diverse medical needs of China’s people in an innovative, socially responsible and commercially viable manner. Pfizer has invested more than USD 1.2 billion in China, establishing four state-of-the-art manufacturing facilities.